Predominant role for C5b-9 in renal ischemia/reperfusion injury

Journal of Clinical Investigation

Volumn 105, Issue 10, 2000, Pages 1363-1371

  Zhou, Wuding ^a   Farrar, Conrad A ^a   Abe, Katsushige ^a   Pratt, Julian R ^a   Marsh, James E ^a   Wang, Yi ^b   Stahl, Gregory L ^c   Sacks, Steven H ^a,d  

^a GUY S HOSPITAL   (United Kingdom)

^b ALEXION PHARMACEUTICALS   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C6; COMPLEMENT MEMBRANE ATTACK COMPLEX; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0034082750     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8621     Document Type: Article

References (57)

1. Hearse, D.J., and Bolli, R. 1992. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc. Res. 26: 101-108.
2. Thadhani, R., Pascual, M., and Bonventre, J.V. 1996. Acute renal failure. N. Engl. J. Med. 334:1448-1460.
3. Bonventre, J.V. 1993. Mechanisms of ischemic acute renal failure. Kidney Int. 43:1160-1178.
4. Troppmann, C., et al. 1995. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation. 59:962-968.
5. Pagtalunan, M.E., Olson, J.L., Tilney, N.L., and Meyer, T.W. 1999. Late consequences of acute ischemic injury to a solitary kidney. J. Am. Soc. Nephrol. 10:366-373.
6. Korthuis, R.J., Smith, J.K., and Carden, D.L. 1989. Hypoxic reperfusion attenuates post ischemic microvascular injury. Am. J. Physiol. 256:H315-H319.
7. Williams, F.M. 1996. Neutrophils and myocardial reperfusion injury. Pharmacol. Ther. 72:1-12.
8. Kilgore, K.S., Friedrichs, G.S., Homeister, J.W., and Lucchesi, B.R. 1994. The complement system in myocardial ischaemia/reperfusion injury. Cardiovasc. Res. 28:437-444.
9. Kelly, K.J., et al. 1996. Intercellular adhesion molecule-1 deficient mice are protected against ischemic renal injury. J. Clin. Invest. 97:1056-1063.
10. Daemen, M.A., van't Veer, C., Wolfs, T.G., and Buurman, W.A. 1999. Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. J. Immunol. 162:5506-5510.
11. Rabb, H., O'Meara, Y.M., Maderna, P., Coleman, P., and Brady, H.R. 1997. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 51:1463-1468.
12. Takada, M., Chandraker, A., Nadeau, K.C., Sayegh, M.H., and Tilney, N. 1998. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J. Clin. Invest. 100:1199-1203.
13. Hugli, T.E. 1983. The chemistry and biology of C3a, C4a and C5a and their effects on cells. In Biological response mediators and modulators. J.T. August, editor. Academic Press. New York, New York, USA. 99-116.
14. del Balzo, U.H., Levi, R., and Polley, M.J. 1985. Cardiac dysfunction caused by purified human C3a anaphylatoxin. Proc. Natl. Acad. Sci. USA. 82:886-890.
15. Tonnesen, M.G., et al. 1989. Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family. J. Clin. Invest. 83:637-646.
16. Foreman, K.E., Glovsky, M.M., Warner, R.L., Horvath, S.J., and Ward, P.A. 1996. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation. 20:1-9.
17. Biancone, L., et al. 1994. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int. 45:451-460.
18. Kilgore, K.S., et al. 1997. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am. J. Pathol. 150:2019-2031.
19. Hansch, G.M., Seitz, M., and Betz, M. 1987. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int. Arch. Allergy Immunol. 82:317-320.
20. Seeger, W., Suttorp, N., Hellwig, A., and Bhakdi, S. 1986. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J. Immunol. 137:1286-1293.
21. Camphell, A.K., and Morgan, B.P. 1985. Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack. Nature. 317:164-166.
22. Wiedmer, T., Esmon, C.T., and Sims, P.J. 1986. Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood. 68:875-880.
23. Weisman, H.F., et al. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 249:146-151.
24. Ikai, M., et al. 1996. Complement plays an essential role in shock following intestinal ischaemia in rats. Clin. Exp. Immunol. 106:156-159.
25. Eppinger, M.J., Deeb, G.M., Bolling, S.F., and Ward, P.A. 1997. Mediators of ischemia-reperfusion injury of rat lung. Am. J. Pathol. 150:1773-1784.
26. Weiser, M.R., et al. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:2343-2348.
27. Jones, S.G., Morrisey, K., Williams, J.D., and Phillips, A.O. 1999. TGF-betal stimulates the release of pre-formed bfGf from renal proximal tubular cells. Kidney Int. 56:83-91.
28. David, S., et al. 1997. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol. Dial. Transplant. 12:51-56.
29. Burton, C.J., Combe, C., Walls, J., and Harris, K.P. 1996. Fibronectin production by human tubular cells: the effect of apical protein. Kidney Int. 50:760-767.
30. Deckers, J.G., et al. 1998. IL-4 and IL-13 augment cytokine and CD40- induced RANTES production by human renal tubular epithelial cells in vitro. J. Am. Soc. Nephrol. 9:1187-1193.
31. Hearse, D.J., Maxwell, L., Saldanha, C., and Gavin, J.B. 1993. The myocardial vasculature during ischemia and reperfusion: a target tor injury and protection. J. Mol. Cell. Cardiol. 25:759-800.
32. Wessels, M.R., et al. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA. 92:11490-11494.
33. Fischer, M.B., et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549-556.
34. Orren, A., Wallance, M.E., Horbart, M.J., and Lachmann, P.J. 1989. C6 polymorphism and C6 deficiency in site strains of the mutation-prone Peru-Coppock mice. Complement Inflamm. 6:295-296. (Abstr.)
35. Rabb, H., et al. 1996. Renal ischemic-reperfusion in jury in L-selectin-deficient mice. Am. J. Physiol. 271:F408-F413.
36. Drury, R.A.B., and Wallington, E.A. 1980. Carleton's histological technique. Oxford University Press. Oxford, United Kingdom. 228-229.
37. Hillegass, L.M., Griswold, D.E., Brickson, B., and Albrightson-Winslow, C. 1990. Assessment of myeloperoxidase activity in whole rat kidney. J. Pharmacol. Methods. 24:285-295.
38. Wang, V., Rollins, S.A., Madri, J.A., and Matis, L.A. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. USA. 92:8955-8959.
39. Timmerman, J.J., et al. 1997. Complement C6 and C2 biosynthesis in syngeneic PVG/c- and PVG/c+ rat strains. Scand J. Immunol. 46:366-372.
40. Klerx, J.P., Beukelman, C.J., Van Dijk, H., and Willers, J.M. 1983. Microassay tor colorimetric estimation of complement activity in guinea pig, human and mouse serum. J. Immunol. Methods. 63:215-220.
41. Vakeva, A.P., et al. 1998. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation. 97:2259-2267.
42. Colgan, S.P., Dzus, A.L., and Parkos, C.A. 1996. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration. J. Exp. Med. 184:1003-1015.
43. Mayadas, T.N., Johnson, R.C., Rayburn, H., Hynes, R.O., and Wagner, D.D. 1993. Leukocyte rolling and extravasation are severely compromised in P selectin deficient mice. Cell. 74:541-554.
44. Sengelov, H. 1995. Complement receptors in neutrophils. Crit. Rev. Immunol. 15:107-131.
45. Wetsel, R.A. 1995. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Immunol. Lett. 44:183-187.
46. Nataf, S., Davoust, N., Ames, R.S., and Barnum, S.R. 1999. Human T cells express the C5a receptor and are chemoattracted to C5a. J. Immunol. 162:4018-4023.
47. Tofukuji, M., et al. 1998. Anti-c5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction. J. Thorac. Cardiovasc. Surg. 116:1060-1068.
48. Williams, J.P., et al. 1999. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86:938-942.
49. Heller, T., et al. 1999. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163:985-994.
50. Vakeva, A.P., et al. 1998. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation. 97:2259-2267.
51. Pemberton, M., Anderson, G., Vetvicka, V., Justus, D.E., and Ross, G.D. 1993. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J. Immunol. 150:5104-5113.
52. Murohara, T., Guo, J.P., Delyani, J.A., and Lefer, A.M. 1995. Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury. Methods Find. Exp. Clin. Pharmacol. 17:499-507.
53. Ichida, S., Yuzawa, Y., Okada, H., Yoshioka, K., and Matsuo, S. 1994. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int. 46:89-96.
54. Kashgarian, M. 1998. Acute tubular necrosis and ischemic renal injury. In Heptinstall's pathology of the kidney. J.C. Jennett, J.L. Olson, M.M. Schwartz, and F.G. Silva, editors. Lippincott-Raven Publishers. New York, New York, USA/Philadelphia, Pennsylvania, USA. 863-890.
55. Litt, M.R., et al. 1989. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation. 80:1816-1827.
56. Vitola, J.V., Forman, M.H., Holsinger, J.P., Atkinson, J.B., and Murray, J.J. 1997. Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. Am. Heart J. 133:315-322.
57. Wang, C., et al. 1995. Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Blood. 85:2570-2578.